USPTO Extends Cancer Immunotherapy Pilot Program – The National Law Review
|
USPTO Extends Cancer Immunotherapy Pilot Program
The National Law Review On June 29th, 2016, the USPTO announced the Cancer Immunotherapy Pilot Program to allow expedited examination of patent applications that pertain to cancer immunotherapy. Under the Program and after proper petition, the USPTO has examined … |
